ID: ALA4280560

Max Phase: Preclinical

Molecular Formula: C12H19N3O6

Molecular Weight: 301.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC12CC3CC(CO[N+](=O)[O-])(C1)CC(CO[N+](=O)[O-])(C3)C2

Standard InChI:  InChI=1S/C12H19N3O6/c13-12-3-9-1-10(5-12,7-20-14(16)17)4-11(2-9,6-12)8-21-15(18)19/h9H,1-8,13H2

Standard InChI Key:  PHNDBLVSIRMDAO-UHFFFAOYSA-N

Associated Targets(non-human)

Aorta 2975 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.30Molecular Weight (Monoisotopic): 301.1274AlogP: 1.07#Rotatable Bonds: 6
Polar Surface Area: 130.76Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.69CX LogP: 0.90CX LogD: -1.94
Aromatic Rings: 0Heavy Atoms: 21QED Weighted: 0.57Np Likeness Score: 0.07

References

1. Liu Z, Yang S, Jin X, Zhang G, Guo B, Chen H, Yu P, Sun Y, Zhang Z, Wang Y..  (2017)  Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases.,  (1): [PMID:30108699] [10.1039/C6MD00509H]

Source